what is xareltoOur attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to accomplish so may be grounds for compensation. Our lawyers are functioning challenging to acquire those hurt by the drug the compensation they are entitled to.

Although bleeding is actually a typical complication connected with anticoagulants, it has been alleged that Xarelto is much more harmful than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, in the event of an emergency, sufferers might be at threat for irreversible bleeding troubles, including life-threatening internal and gastrointestinal hemorrhaging.

Should you or even a loved 1 suffered a critical bleeding event right after taking xarelto liver enzymes, you may have legal recourse. For far more information, make contact with us nowadays to have your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in instances of death, funeral expenditures. In addition, they are searching for punitive damages, that are usually awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for much more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.